✦ LIBER ✦

Predictive factors of disease relapse after therapy with lymphoblastoid interferon (L-IFN) in chronic hepatitis C (CHC)

✍ Scribed by Camps, J; Gareín-Granero, M; Riezu-Boj, J.I.; Larrea, E; de Alsva, E; Civeira, M.P.; Castilla, A; Prieto, J

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors of response to lympho

✍ Camps, J; Crisóstomo, T; García-Granero, M; Riezu-Boj, JI; Castilla, A; Civeira, 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Effectiveness of long term lymphoblastoi

✍ Camps, J.; Castilla, A.; Riezu-Boj, J.I.; Civeira, M.P.; Prieto, J. 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Combination thymosin α1 (Tα1) and lympho

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Retreatment of chronic hepatitis C (CHC)

✍ L Chemello; L Cavalletto; E Bernardinello; C Donada; F Belussi; P Casarin; F Urb 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 168 KB

“Rebound” phenomenon of hepatitis C vire

✍ Hiroshi Hanada; Keisuke Hino; Kaori Fujii; Muneko Okazaki; Kiwamu Okita 📂 Article 📅 1995 🏛 Springer Japan 🌐 English ⚖ 407 KB

Prolongation of daily administration of

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 170 KB